A. Labelle

发表

V. Knott, C. Mahoney, A. Labelle, 1999, Schizophrenia Research.

Change in the Neural Response to Auditory Deviance Following Cognitive Therapy for Hallucinations in Patients With Schizophrenia

V. Knott, A. Labelle, D. Shah, 2020, Frontiers in Psychiatry.

Decreased fMRI activity in the hippocampus of patients with schizophrenia compared to healthy control participants, tested on a wayfinding task in a virtual town

Andra M. Smith, V. Bohbot, A. Labelle, 2013, Psychiatry Research: Neuroimaging.

Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test.

C. Benkelfat, S. Lal, D. Bloom, 2002, Archives of general psychiatry.

Structural Hippocampal Anomalies in a Schizophrenia Population Correlate with Navigation Performance on a Wayfinding Task

Andra M. Smith, V. Bohbot, P. Boyer, 2014, Front. Behav. Neurosci..

Dopamine Beta‐Hydroxylase (DBH) gene and schizophrenia phenotypic variability: A genetic association study

Kenji Yamamoto, Pierre Lalonde, Joel Gelernter, 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment

V. Knott, C. Mahoney, A. Labelle, 2001, Schizophrenia Research.

Interaction of Background Noise and Auditory Hallucinations on Phonemic Mismatch Negativity (MMN) and P3a Processing in Schizophrenia

V. Knott, A. Labelle, D. Fisher, 2020, Frontiers in Psychiatry.

Mismatch negativity-indexed auditory change detection of speech sounds in early and chronic schizophrenia

V. Knott, A. Labelle, P. Tibbo, 2019, Psychiatry Research: Neuroimaging.

Homicide of strangers by people with a psychotic illness.

M. Large, A. Labelle, O. Nielssen, 2011, Schizophrenia bulletin.

Auditory verbal hallucinations in schizophrenia correlate with P50 gating

V. Knott, A. Labelle, Dylan Smith, 2013, Clinical Neurophysiology.

Auditory hallucinations and the mismatch negativity: processing speech and non-speech sounds in schizophrenia.

V. Knott, A. Labelle, D. Fisher, 2008, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

CDP-choline: Effects of the procholine supplement on sensory gating and executive function in healthy volunteers stratified for low, medium and high P50 suppression

V. Knott, A. Labelle, V. Ilivitsky, 2014, Journal of psychopharmacology.

Neuropsychological change in schizophrenia after 6 weeks of clozapine

A. Labelle, S. Purdon, L. Boulay, 2001, Schizophrenia Research.

Retention Rates in Placebo- and Nonplacebo-Controlled Clinical Trials of Schizophrenia

A. Labelle, Y. Lapierre, L. Boulay, 1999, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

The treatment of negative symptoms: a clinical and methodological study.

A. Malla, A. Labelle, J. Denis, 1999, International clinical psychopharmacology.

Phase-IV Multicentre Clinical Study of Risperidone in the Treatment of Outpatients with Schizophrenia

A. Labelle, L. Beauclair, G. Chouinard, 1998, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Lack of association between the hSKCa3 channel gene CAG polymorphism and schizophrenia.

M. Alda, C. Benkelfat, S. Lal, 1999, American journal of medical genetics.

T102C polymorphism in the 5HT2A gene and schizophrenia: relation to phenotype and drug response variability.

M. Alda, C. Benkelfat, S. Lal, 1999, Journal of psychiatry & neuroscience : JPN.

Improvement of procedural learning in schizophrenia after six months of treatment with clozapine

A. Labelle, S. Purdon, B. Waldie, 2000, Schizophrenia Research.

Adolescent murderers.

A. Labelle, B. Jones, J. Bradford, 1991, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Apolipoprotein E genotype in schizophrenia.

C. Benkelfat, S. Lal, R. Palmour, 1996, American journal of medical genetics.

Age of onset in familial and sporadic schizoph4.4.renia

M. Alda, A. Labelle, B. Jones, 1996, Acta psychiatrica Scandinavica.

Risperidone Treatment for Severe Negative Symptoms

A. Labelle, B. Jones, S. Purdon, 1994, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

A pilot study of the safety and tolerance of SCH 39166 in patients with schizophrenia.

D. Naber, A. Labelle, B. Jones, 1998, Journal of psychiatry & neuroscience : JPN.

Risperidone Treatment of Outpatients with Schizophrenia: No Evidence of Sex Differences in Treatment Response

A. Labelle, F. Dunbar, M. Light, 2001, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Risperidone in the Treatment of Pervasive Developmental Disorder

A. Labelle, B. Jones, S. Purdon, 1994, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Managing pathologic aggression in people with psychotic disorders.

A. Labelle, D. Bourget, 2012, Journal of psychiatry & neuroscience : JPN.

Alterations of Resting EEG in Hallucinating and Nonhallucinating Schizophrenia Patients

V. Knott, A. Labelle, D. Fisher, 2020, Clinical EEG and neuroscience.

EEG Hemispheric Asymmetry as a Predictor and Correlate of Short-term Response to Clozapine Treatment in Schizophrenia

V. Knott, C. Mahoney, A. Labelle, 2000, Clinical EEG.

Acute Nicotine Alteration of Sensory Memory Impairment in Smokers With Schizophrenia

V. Knott, A. Labelle, L. Dulude, 2010, Journal of Clinical Psychopharmacology.

Analysis of 14 CAG repeat-containing genes in schizophrenia.

A Labelle, M. Alda, C. Benkelfat, 1999, American journal of medical genetics.

Association study of the trinucleotide repeat polymorphism within SMARCA2 and schizophrenia

C. Benkelfat, S. Lal, M. Krebs, 2006, BMC Genetics.

Familial Paraphilia: A Pilot Study with the Construction of Genograms

M. Alda, A. Labelle, J. Bradford, 2012, ISRN psychiatry.

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.

A Labelle, G. Remington, D. Bloom, 1993, Journal of clinical psychopharmacology.

Association between the methylenetetrahydrofolate reductase 677C→T missense mutation and schizophrenia

C. Benkelfat, S. Lal, R. Rozen, 2000, Molecular Psychiatry.

Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia.

V. Knott, A. Labelle, Dylan Smith, 2019, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

Assessing the acute effects of CDP-choline on sensory gating in schizophrenia: A pilot study

V. Knott, A. Labelle, Ashley Baddeley, 2018, Journal of psychopharmacology.

An acute dose, randomized trial of the effects of CDP-Choline on Mismatch Negativity (MMN) in healthy volunteers stratified by deviance detection level

Verner Knott, Dylan Smith, V. Knott, 2015 .

Expert Canadian consensus suggestions on the rational, clinical use of ziprasidone in the treatment of schizophrenia and related psychotic disorders

P. Lalonde, A. Malla, A. Labelle, 2005, Neuropsychiatric disease and treatment.

CAA insertion polymorphism in the 3'UTR of Nogo gene on 2p14 is not associated with schizophrenia.

L. DeLisi, C. Benkelfat, S. Lal, 2005, Brain Research. Molecular Brain Research.

EEG coherence following acute and chronic clozapine in treatment-resistant schizophrenics.

V. Knott, C. Mahoney, A. Labelle, 2002, Experimental and clinical psychopharmacology.

Psychiatry and the Law First-Episode Psychosis and Homicide: A Diagnostic Challenge

A. Labelle, Pierre Tessier, D. Bourget, 2004 .

DRD3 and DAT1 genes in schizophrenia: an association study.

C. Benkelfat, S. Lal, D. Bloom, 2000, Journal of psychiatric research.

Evidence review and clinical guidance for the use of ziprasidone in Canada

V. Taylor, P. Lalonde, A. Malla, 2013, Annals of General Psychiatry.

Neurocognitive effects of acute choline supplementation in low, medium and high performer healthy volunteers

Verner Knott, Dylan Smith, V. Knott, 2015, Pharmacology Biochemistry and Behavior.

Homicide, infanticide, and filicide.

A. Labelle, D. Bourget, 1992, The Psychiatric clinics of North America.

MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patients

V. Knott, A. Labelle, A. Millar, 2011, Schizophrenia Research.

Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol.

A. Malla, A. Labelle, S. Purdon, 2001, Journal of psychiatry & neuroscience : JPN.

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.

A Labelle, E. Stip, G. Tollefson, 2000, Archives of general psychiatry.

Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteers

C. Benkelfat, S. Lal, R. Palmour, 2002, Schizophrenia Research.

An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine

V. Knott, A. Labelle, Dylan Smith, 2023, Journal of psychopharmacology.

An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states

D. Naber, A. Labelle, B. Jones, 1995, Psychopharmacology.

The acute dose and baseline amplitude-dependent effects of CDP-choline on deviance detection (MMN) in chronic schizophrenia: A pilot study.

V. Knott, A. Labelle, J. Choueiry, 2021, Experimental and clinical psychopharmacology.

Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness

V. Knott, A. Labelle, D. Fisher, 2012, Schizophrenia Research.

Nicotine and the hallucinating brain: Effects on mismatch negativity (MMN) in schizophrenia

V. Knott, A. Labelle, Dylan Smith, 2012, Psychiatry Research.

Effects of auditory hallucinations on the mismatch negativity (MMN) in schizophrenia as measured by a modified 'optimal' multi-feature paradigm.

V. Knott, A. Labelle, Dylan Smith, 2011, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

Polymorphism in the cell division cycle 45 like gene and schizophrenia.

C. Benkelfat, D. Bloom, P. Lalonde, 2001, American journal of medical genetics.

Procedural learning improvements after six weeks of clozapine treatment

N. Woodward, A. Labelle, S. Purdon, 2002, Schizophrenia Research.

Increased prevalence of schizophrenia spectrum disorders in relatives of neuroleptic-nonresponsive schizophrenic patients

Pierre Lalonde, C. Benkelfat, S. Lal, 2005, Schizophrenia Research.

A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.

S. Kapur, G. Remington, J. Reiss, 2006, The American journal of psychiatry.

Attenuation of mismatch negativity (MMN) and novelty P300 in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness

V. Knott, A. Labelle, Dylan Smith, 2014, Biological Psychology.

Auditory hallucinations and the P3a: Attention-switching to speech in schizophrenia

V. Knott, A. Labelle, D. Fisher, 2010, Biological Psychology.